Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 90,276,097
- Share change
- +8,510,807
- Total reported value
- $99,304,130
- Price per share
- $1.10
- Number of holders
- 28
- Value change
- +$9,366,353
- Number of buys
- 23
- Number of sells
- 6
Report period
Q3 2023
Institutions
28
Top holders
10
XTNT full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
73,114,592
|
$67,989,259 | — | 30 Jun 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
4.4%
|
6,227,559
|
$5,791,007 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.91%
|
1,279,052
|
$1,189,390 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.43%
|
597,010
|
$555,000 | — | 30 Jun 2023 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.19%
|
262,024
|
$243,656 | — | 30 Jun 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
114,500
|
$106,474 | — | 30 Jun 2023 | |
| Midwest Professional Planners, LTD. |
13F
|
Company |
0.03%
|
40,744
|
$37,888 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
27,109
|
$25,209 | — | 30 Jun 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
25,238
|
$23,469 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
23,666
|
$22,007 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
23,593
|
$21,939 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
21,061
|
$19,585 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
7,013
|
$6,522 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,200
|
$1,116 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
316
|
$291 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
311
|
$289 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
143
|
$133 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
106
|
$98 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
53
|
$49 | — | 30 Jun 2023 | |
| Matthew Rizzo |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Michael Eggenberg |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Jeffrey J. Peters |
3/4/5
|
Director |
—
class O/S missing
|
448,546
|
$273,209 | — | 15 Aug 2022 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q3 2023
As of 30 Sep 2023,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,276,097 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Altium Capital Management LP, Nantahala Capital Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, AMH Equity Ltd, AWM Investment Company, Inc., GEODE CAPITAL MANAGEMENT, LLC, Crescent Grove Advisors, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
19
Q3 2023 holders
28
Holder diff
9
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.